期刊論文
| 期間 |
內容 |
| |
Yu-Chin Liu*, Tsung-Jen, Lin, Kowit-Yu Chong, Guan-Ying Chen, Chia-Yu Kuo, Yi-Yun, Lin, Chia-Wei Chang, Ting-Feng Hsiao, Chih-Liang Wang, Yo-Chen Shih, Chia-Jung Yu. Targeting the ERK1/2 and p38 MAPK pathways attenuates Golgi tethering factor golgin-97 depletion-induced cancer progression in breast cancer. Cell Communication and Signaling. 2025 Jan 13;23(1):22. doi: 10.1186/s12964-024-02010-0. |
| |
Jie-Xin Huang, Chun-I Wang, Chia-Yu Kuo, Ting-Wei Chang, Yu-Chin Liu, Ting-Feng Hsiao, Chih-Liang Wang, Chia-Jung Yu. Oxidative stress mediates nucleocytoplasmic shuttling of KPNA2 via AKT1-CDK1 axis-regulated S62 phosphorylation. FASEB Bioadvances, 2024 Jul 5;6(8):276-288. doi: 10.1096/fba.2024-00078. |
| |
Hsiang-Pu Feng*, Yu-Chin Liu*, Chih-Liang Wang, Wei-Chao Liao, Jau-Song Yu, Chia-Jung Yu. Acetylation regulates the nucleocytoplasmic distribution and oncogenic function of karyopherin alpha 2 in lung adenocarcinoma. Biochemical and Biophysical Research Communications, 2023 Jun 4:659:96-104. doi: 10.1016/j.bbrc.2023.04.014. |
| |
Pei-Yi Chu, Wei-Chieh Huang, Shiao-Lin Tung, Chung-Ying Tsai, Chih Jung Chen, Yu-Chin Liu, Chia-Wen Lee, Yang-Hsiang Lin, Hung-Yu Lin, Cheng-Yi Chen, Chau-Ting Yeh, Kwang-Huei Lin & Hsiang-Cheng Chi. IFITM3 promotes malignant progression, cancer stemness and chemoresistance of gastric cancer by targeting MET/AKT/FOXO3/c-MYCaxis. Cell & Bioscience, 2022 Aug 8;12(1):124. doi: 10.1186/s13578-022-00858-8. |
| |
Yang-Hsiang Lin*, Yu-Chin Liu*, Cheng-Yi Chen, Hsiang-Cheng Chi, Meng-Han Wu, Po-Shuan Huang, Cheng-Chih Chang, Tzu-Kang Lin, Chau-Ting Yeh, Kwang-Huei Lin. LPAL2 Suppresses Tumor Growth and Metastasis of Hepatocellular Carcinoma by Modulating MMP9 Expression. Cells, 2022 Aug 22;11(16):2610. doi: 10.3390/cells11162610. |
| |
Yu-Chin Liu*, Yang-Hsiang Lin, Hsiang-Cheng Chi, Po-Shuan Huang, Chia-Jung Liao, Yu-Syuan Liou, Chiao-Chun Lin, Chia-Jung Yu, Chau-Ting Yeh, Ya-Hui Huang, Kwang-Huei Lin. CRNDE acts as an epigenetic modulator of the p300/YY1 complex to promote HCC progression and therapeutic resistance. Clinical Epigenetics, 2022 Aug 23;14(1):106. doi: 10.1186/s13148-022-01326-3. |
| |
Wei-Chao Liao*, Tsung-Jen Lin*, Yu-Chin Liu*, Yu-Shan Wei, Guan-Ying Chen, Hsiang-Pu Feng, Yi-Feng Chang, Hsin-Tzu Chang, Chih-Liang Wang, Hsinag-Cheng Chi, Chun-I Wang, Kwang-Huei Lin, Wei-Ting Ou Yang, Chia-Jung Yu. Nuclear accumulation of KPNA2 impacts radioresistance through positive regulation of the PLSCR1-STAT1 loop in lung adenocarcinoma. Cancer Science, 2022 Jan;113(1):205-220. doi: 10.1111/cas.15197. |
| |
Yu-Chin Liu*, Chau-Ting Yeh, and Kwang-Huei Lin. Cancer Stem Cell Functions in Hepatocellular Carcinoma and Comprehensive Therapeutic Strategies. Cells, 2020 May 26;9(6):1331. doi: 10.3390/cells9061331. |
| |
Yu-Chin Liu*, Li-Feng Lu, Chia-Jung Li, Nian-Kang Sun, Jing-You Guo, Ya-Hui Huang, Chau-Ting Yeh, Chang Chuck C.-K. Chao. Hepatitis B virus X protein induces RHAMM- dependent motility in hepatocellular carcinoma cells via PI3K-Akt-Oct-1 signaling. Molecular Cancer Research, 2020 Mar;18(3):375-389. doi: 10.1158/1541-7786.MCR-19- 0463. |
| |
Yu-Chin Liu*, Chau-Ting Yeh, and Kwang-Huei Lin. Molecular Functions of Thyroid Hormone Signaling in Regulation of Cancer Progression and Anti-Apoptosis. International Journal of Molecular Sciences, 2019 Oct 9;20(20):4986. doi: 10.3390/ijms20204986. |
| |
Lin, Yi.-Te., Yu-Chin Liu, Chang Chuck C.-K. Chao. Inhibition of JNK and prothymosin-alpha sensitizes hepatocellular carcinoma cells to cisplatin. Biochem Pharmacol., 2016 Dec 15:122:80-89. doi: 10.1016/j.bcp.2016.10.003. |
| |
Yu-Chin Liu*, Pu-Yuan Chang Chuck C.-K. Chao. CITED2 silencing sensitizes cancer cells to cisplatin by inhibiting p53 trans-activation and chromatin relaxation on the ERCC1 DNA repair gene. Nucleic Acids Research, 2015 Dec 15;43(22):10760-81. doi: 10.1093/nar/gkv934. |
|
研討會論文
| 期間 |
內容 |
| |
Yu-Chin Liu*, Tsung-Jen, Lin, Kowit-Yu Chong, Guan-Ying Chen, Chia-Yu Kuo, Yi-Yun Lin, Chia-Wei Chang, Ting-Feng Hsiao, Chih-Liang Wang, Yo-Chen Shih, Chia-Jung Yu (2025, Jan). Mitigating breast cancer progression induced by Golgi tethering factor golgin-97 depletion through targeting ERK1/2 and p38 MAPK pathways. 第 30 屆細胞及分子生物新知研討會暨 30 屆慶祝活動 |
| |
Yu-Chin Liu*, Chia-Yu Kuo, Chia-Jung Yu (2024, Nov). Phospholipid Scramblase 1 as a Multifunctional Signaling Molecule Promotes Chemoradioresistance in Non- Small Cell Lung Cancer. 台灣生物化學及分子生物學會 2024 秋令營. |
| |
Ke-Wei Lin, Yu-Chin Liu, Guan-Ying Chen, Chia-Jung Yu (2023, Nov). Study the molecular mechanisms of KPNA2-mediated IFN signaling activation and extracellular vesicle secretion in promoting chemoradiotherapy resistance in lung cancer cells. 2023 生化秋令營暨免疫腫瘤轉譯研究研討會. |
| |
Pei-Zhen Huang, Yu-Chin Liu, Guan-Ying Chen, Chia-Jung Yu (2023, Nov). Investigation of the potential molecular mechanisms of PLSCR1-mediated chemoresistance via proteomics approaches. . 2023 生化秋令營暨免疫腫瘤轉譯研究研討會. |
| |
Yu-Chin Liu*, Chia-Yu Kuo, Wen-Yu Chuang, Chi-Ju Yeh, Chih-Liang Wang, Chia-Jung Yu (2023, Nov). The Potential Role and Impact of PLSCR1 in Promoting Chemoradioresistance in Non-Small Cell Lung Cancer. 2023 生化秋令營暨免疫腫瘤轉譯研究研討會. |
| |
Yu-Chin Liu*, Tsung-Jen, Lin, Guan-Ying Chen, Yi-Yun Lin, Chia-Wei Chang, Ting-Feng Hsiao, Chih-Liang Wang, Yo-Chen Shih, Chia-Jung Yu (2023, Nov). Depletion of the Golgi-Tethering Factor Golgin-97 in Breast Cancer Promotes Cancer Progression through Modulation of MAPK Signaling and Inflammatory Response. 2023 生化秋令營暨免疫腫瘤轉譯研究研討會. |
| |
Yu-Chin Liu*, Yang-Hsiang Lin, and Kwang-Huei Lin (2022, May). CRNDE acts as an epigenetic modulator of the p300/YY1 complex to promote HCC progression and therapeutic resistance. 第十七屆前瞻生物醫學科學新知研討會, 國家生技研究園區 C 棟 C201 國際會議廳. |
| |
Kwang-Huei Lin, Yu-Chin Liu, Yang-Hsiang Lin (2019, Jan). LncCGU1 and AFP serve as important prognostic marker in non-hepatitis B non-hepatitis C hepatocellular carcinoma. AACR Annual Meeting 2019, Atlanta. |
|
